UniProtKB/Swiss-Prot Q14790 : Variant p.Ser219Thr
Caspase-8
Gene: CASP8
Feedback ?
Variant information
Variant position:
219
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LB/B
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Serine (S) to Threonine (T) at position 219 (S219T, p.Ser219Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from small size and polar (S) to medium size and polar (T)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Polymorphism:
Genetic variations in CASP8 are associated with reduced risk of lung cancer [MIM:211980 ] in a population of Han Chinese subjects. Genetic variations are also associated with decreased risk of cancer of various other forms including esophageal, gastric, colorectal, cervical, and breast, acting in an allele dose-dependent manner.
Additional information on the polymorphism described.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
219
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
479
The length of the canonical sequence.
Location on the sequence:
GEELCGVMTISDSPREQDSE
S QTLDKVYQMKSKPRGYCLII
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GEELCGVMTISDSPREQDSES QTLDKVYQMKSKPRGYCLII
Mouse DEMSLKMAELCDSPREQDSES RTSDKVYQMKNKPRGYCLII
Rat DEVTIKMQDMWDSPGEQESES LNSDNVYQMKSKPRGYCLIF
Drosophila GTAAMAVKQEIESDNQQSYCS TQIDAL-KLTRENAGIALII
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
217 – 374
Caspase-8 subunit p18
Modified residue
211 – 211
Phosphoserine
Modified residue
224 – 224
N6-acetyllysine
Alternative sequence
184 – 267
Missing. In isoform 3.
Alternative sequence
184 – 220
ERSSSLEGSPDEFSNGEELCGVMTISDSPREQDSESQ -> DFGQSLPNEKQTSGILSDHQQSQFCKSTGESAQTSQH. In isoform 6.
Alternative sequence
199 – 235
GEELCGVMTISDSPREQDSESQTLDKVYQMKSKPRGY -> DFGQSLPNEKQTSGILSDHQQSQFCKSTGESAQTSQH. In isoform 5.
Literature citations
Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS THR-219 AND HIS-285;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.